The largest database of trusted experimental protocols

4 protocols using recombinant rat beta ngf

1

Neurite Outgrowth Assay in PC12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neurite outgrowth assay in PC12 was performed as described previously [39 (link)]. Briefly, PC12 cells (1 × 104 cells/well) were cultured on a collagen type IV-coated 24-well plate for 24 h. To induce neurite growth, the cells were replaced with differentiation medium consisting serum-free DMEM, 100 ng/mL recombinant rat beta NGF (R&D Systems, Minneapolis, MN, USA), 1% N2 supplement (Thermo Fisher Scientific) and 0.5% FBS for 4 days. To investigate the effect of LOHP on neural differentiation of the PC12 cells, the cells were exposed to DM containing a combination of LOHP (200 nM), EFVF, and each constituent or amifostine (0.5 mM) as described earlier. A neurite outgrowth analysis was performed using a phase contrast bright-field inverted microscope (IX71, Olympus, Tokyo, Japan). Digitalized morphometric images of each well were obtained and the fields containing more than 20 cells were captured. The cells bearing neurite that had at least one neurite with a length longer than the diameter of the cell body were counted from four captured images and expressed as a percentage of the total of 80 cells counted from the images. Total neurite lengths were measured by manually tracing the length of the neurites using the Meta Morph image software (Molecular Devices).
+ Open protocol
+ Expand
2

Neurite Outgrowth in PC12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC12 cells (1 × 104 cells/well) were plated on a 24-well tissue culture plate pre-coated with collagen type IV (Corning) containing a complete culture medium. After 24 h, the medium was replaced with serum free DMEM containing 100 ng/mL recombinant rat beta-NGF (R&D systems, Cat # 556-NG, Minneapolis, MN, USA), N2 supplement (Thermo Fisher Scientific, Cat # 17502048) and 0.5 % FBS to induce neurite growth in the presence or absence of oxaliplatin (200 nM, LC Laboratories, Woburn, MA, USA). WLR (25 and 100 μg/mL) or amifostine (0.5 mM, Santa Cruz Biotechnology, Dallas, TX, USA) were co-treated with oxaliplatin. Three days after the drug treatment, a morphometric analysis was done on digitalized images of PC12 cells taken with an inverted microscope (IX71, Olympus, Center Valley, PA, USA). Images of fields with more than 20 cells were captured and used for the image analysis. The differentiation of cells induced by NGF was examined, and cells that had at least one neurite with a length equal to the cell body diameter were counted. The number of neurite bearing cells was expressed as a percentage of the total cells. Total neurite length was determined by manually tracing the length of the neurite per cell using the MetaMorph image software (Molecular Devices).
+ Open protocol
+ Expand
3

Characterization of Phagocytic Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC12 cells and MG6 cells27 (link)28 (link) were obtained from RIKEN BRC, Japan. PC12 cells were maintained in DMEM (Nakarai, Japan) supplemented with 10% FBS (Biowest) and 10% horse serum (Life technologies), and MG6 cells were maintained in DMEM supplemented with 10% FBS, 10 μg/ml insulin and 100 μM 2-mercaptoethanol. Recombinant rat beta-NGF and pan-caspase OPH inhibitor Q-VD26 (link) were from R&D systems. Monoclonal antibody against C3a/C3 (clone K13/16) and IgG isotype control antibody were from BioLegend. The NIH3T3 transformants expressing Tim4 (3T3/Tim4) and rD89E were described previously31 (link)32 (link). When indicated, membranes of MG6 cells or exosomes were labelled with PKH26 red fluorescent cell linker kit (Sigma) according to the manufacturer's instructions.
+ Open protocol
+ Expand
4

Signaling Pathway Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant rat EGF was obtained from PeproTech (Cat. #400–25) and recombinant rat beta-NGF from R&D Systems (#556-NG-100). Recombinant human NRG1α (Cat. #296-HR) and NRG1β (Cat. #396-HB/CF) were obtained from R&D Systems. All ligands were reconstituted in sterile PBS containing 1 mg/ml bovine serum albumin (BSA) (Roche #03116956001). The following antibodies were used: phospho-p44/42 MAPK (ERK1/2) (pThr202/pTyr204) (E10) (Cell Signaling Technology (CST) #9106), p44/42 MAPK (ERK1/2) (L34F12) (CST #4696), Grb2 (C-23) (Santa Cruz #sc-255) and Grb2 (CST #3972), phospho-EGFR (pTyr1173) (53A5) (CST #4407), phospho-EGFR (pTyr845) (CST #2231), phospho-EGFR (pTyr1086) (CST #2220), phospho-EGFR (pTyr845) (CST #2234), hEGFR (Lab Vision Ab-15: ThermoFisher Sci MS-665-P0), EGFR (CST #2232), phospho-TrkA (pTyr674/675) (C50F3) (CST #4621), phospho-TrkA (pTyr490) (CST #9141), phospho-TrkA (pTyr785) (C67C8) (CST #4168), phospho-TrkA (pTyr785) (R&D #AF5479), TrkA (R&D #AF1056), Rap1A/Rap1B (26B4) (CST #2399), FRS2 (Fisher Sci #PA124685), phospho-ErbB4 (pTyr1242) (4C6) (Santa Cruz #sc81491), phospho-ErbB4 (pTyr1284) (21A9) (CST #4757) and anti-FLAG (CST #2044). The following kinase inhibitors were used: Gö7874 (Calbiochem #365252), erlotinib (CST #5083), and the dynamin GTPase inhibitor Dyngo 4a (Abcam #ab120689).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!